Search

You searched for "invasive"

803 results found
Ophthalmologica journal cover image

OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)

3 April 2024 | | EYE - Vitreo-Retinal
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...
Ophthalmologica journal front cover image.

Scleral fixation using Gore-Tex suture of a subluxated PCIOL

30 June 2025 | | EYE - Cataract, EYE - Refractive
This was a retrospective single-centre study of patients who underwent lasso in-the-bag scleral fixation of a subluxated posterior chamber (PC) intraocular lens (IOL) using the snare technique with Gore-Tex suture from 2019 to 2021. Functional outcome was analysed by clinical...
Ophthalmologica journal cover image.

Vascular density evaluated by SS-OCTA and microperimetry in RP

4 August 2025 | | EYE - Vitreo-Retinal
The aim of this retrospective, observational cross-sectional one-year study was to evaluate the retinal and choroidal vessel density in the macular area with swept-source optical coherence tomography angiography (SS-OCTA) in patients of retinitis pigmentosa (RP), to compare this data with...

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

11 December 2025 | Contracts & Distributors, Research & Development
Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...
Ophthalmology journal cover image.

Medical management and diabetic retinopathy progression

1 February 2015 | | EYE - Vitreo-Retinal
The ACCORD Eye Study was designed to evaluate the benefit of intensive glycaemic control (HbA1c <6.0% vs 7.0-7.9%), intensive systolic blood pressure control (<120mmHg vs. <140mmHg), and combined fenofibrate and simvastatin therapy in the development and progression of diabetic retinopathy....

Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference

5 August 2020 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...
The New England Journal of Medicine cover image.

Intensive diabetes therapy and ocular surgery in type 1 diabetes

1 October 2015 | | EYE - Vitreo-Retinal
The Diabetes Control and Complications Trial (DCCT) ran between 1983 and 1993 and showed that intensive glycaemic control was beneficial in reducing diabetic retinopathy in type 1 patients. There was a 76% reduction in onset of retinopathy and a 52%...

Retinoblastoma management update (part 2): treatment, screening and surveillance, long-term follow-up and new developments

1 February 2017 | | EYE - Oncology
Retinoblastoma treatment requires significant multidisciplinary input, but early detection through raising awareness remains key to improving outcomes. In the second article of a two-part series, Manoj Parulekar discusses retinoblastoma management, screening and research. This article has been published in two...

Informed consent in ophthalmology care in the UK: A critical component of patient‑centred practice

2 April 2025 | | EYE - General
Informed consent is a cornerstone of ethical and legal practice in healthcare, particularly in fields like ophthalmology where specialised interventions can have significant implications for a patient’s vision and quality of life. In the UK, informed consent is not merely...

Take this waltz

1 June 2016 | | EYE - Oculoplastic, EYE - Orbit
My last weekend on-call was the busiest I can remember for a very long time. We were just completely swamped with patients. The weather was not too good that Saturday and it felt like every second inhabitant of our ocean...

Dry eye disease treatments come to the fore at 100%

20 February 2025 | 100%, events, meetings, OSA, industry, business
Guidance on setting up, or enhancing, a Dry Eye disease clinic within the practice will be freely available from OSA members exhibiting at 100% Optical: 1–3 March. The ability to diagnose and treat a major irritation for many is winning...

It’s coming home

3 June 2026 |
Yes, this month sees the return of the four-yearly nightmare for me which is the Fifa World Cup. I have had to live with the torture of watching England being knocked out of the tournament ever since I first started...